Current Issue
Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3
Robert Dream, Managing Director, HDR Company LLC
Advances and Challenges in Vaccine Development and Manufacture
Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...
Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...
Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...
Lifetime Study for JSR Amsphere A3 – Protein A Resin
JSR Life Sciences
Featured Articles
A SMART Platform for Scalable Biotherapeutic Development: cDNA to 200L Single-Use Stirred-Tank Bioreactor
Coupling single-pass TFF before loading onto a chromatography sorbent
Bringing the Freezing of Biopharmaceuticals in From the Cold
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
View All Featured ArticlesHeadline News
Genentech unveils plans to expand manufacturing operations in the United States
FDA approves Johnson & Johnson’s IMAAVY as the first treatment ever cleared for warm autoimmune hemolytic anemia, marking a major step forward for patients
Merck and Moderna’s Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA meets endpoints for recurrence-free survival and distant metastasis-free survival in patients with completely resected stage IIB-IV melanoma
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Reducing Microbiological Risk and Using Quality Tools in the Pharmaceutical Industry
Presented by Don Singer Manager, Steriles Microbiology, for GlaxoSmithKline R&D and Jessica Rayser, Product Manager at Charles River
09th January 2019
Making continuous processing a reality in the pharmaceutical industry
Presented by Mark Gibson Associate Director, Drug Product Manufacture & Delivery for AstraZeneca and Marcel de Matas, Principal Scientist at AstraZeneca
21st August 2013
From Early Stage to Late Stage Development: How to Characterize a Perfusion-based Vaccine Production Process Using QbD?
Presented by Perrine Rouel, Scientist - Up Stream Processing, The Janssen Pharmaceutical Companies of Johnson & Johnson and Tom Jeffery, Application Specialist – Ambr Technology KAM Europe at Sartorius Stedim Biotech
27th March 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Column Packing Protocol for Amsphere A3
Best Practices for Achieving Virus Safety
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
